EVH
Income statement / Annual
Last year (2023), Evolent Health, Inc.'s total revenue was $1.96 B,
an increase of 45.26% from the previous year.
In 2023, Evolent Health, Inc.'s net income was -$113.04 M.
See Evolent Health, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$1.96 B
|
$1.35 B
|
$907.96 M
|
$1.02 B
|
$846.38 M
|
$627.06 M
|
$434.95 M
|
$254.19 M
|
$96.88 M
|
$0.00
|
| Cost of Revenue |
$1.50 B |
$1.04 B |
$657.55 M |
$701.37 M |
$513.06 M |
$327.83 M |
$269.35 M |
$155.18 M |
$57.40 M |
$0.00 |
| Gross Profit |
$460.47 M |
$316.58 M |
$250.41 M |
$321.06 M |
$333.32 M |
$299.24 M |
$165.60 M |
$99.01 M |
$39.48 M |
$0.00 |
| Gross Profit Ratio |
0.23 |
0.23 |
0.28 |
0.31 |
0.39 |
0.48 |
0.38 |
0.39 |
0.41 |
0 |
| Research and Development
Expenses |
$0.00
|
$27.00 M
|
$15.50 M
|
$15.10 M
|
$19.80 M
|
$18.20 M
|
$17.20 M
|
$11.10 M
|
$5.80 M
|
$0.00
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$219.50 M
|
$310.55 M
|
$392.82 M
|
$306.31 M
|
$205.67 M
|
$160.69 M
|
$75.29 M
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$358.11 M
|
$269.27 M
|
$219.50 M
|
$310.55 M
|
$392.82 M
|
$306.31 M
|
$205.67 M
|
$160.69 M
|
$75.29 M
|
$0.00
|
| Other Expenses |
$173.57 M |
$67.20 M |
$60.04 M |
$61.48 M |
$60.91 M |
$109,000.00 |
$171,000.00 |
$4,000.00 |
$7.17 M |
-$25.25 M |
| Operating Expenses |
$531.68 M |
$336.46 M |
$279.54 M |
$372.03 M |
$453.73 M |
$350.82 M |
$238.04 M |
$177.92 M |
$82.45 M |
-$25.25 M |
| Cost And Expenses |
$2.04 B |
$1.37 B |
$937.09 M |
$1.07 B |
$966.79 M |
$678.65 M |
$507.39 M |
$333.09 M |
$139.85 M |
-$25.25 M |
| Interest Income |
$5.26 M |
$1.37 M |
$407,000.00 |
$3.16 M |
$3.99 M |
$3.44 M |
$1.66 M |
$0.00 |
$0.00 |
$0.00 |
| Interest Expense |
$54.21 M |
$15.57 M |
$25.43 M |
$28.34 M |
$14.53 M |
$5.48 M |
$3.64 M |
$723,000.00 |
$293,000.00 |
$0.00 |
| Depreciation &
Amortization |
$123.42 M
|
$90.25 M
|
$60.04 M
|
$60.84 M
|
$66.64 M
|
$44.52 M
|
$32.37 M
|
$17.22 M
|
$7.17 M
|
$0.00
|
| EBITDA |
-$24.79 M
|
$43.75 M
|
$55.66 M
|
-$241.38 M
|
-$245.95 M
|
-$4.15 M
|
-$40.40 M
|
-$220.31 M
|
-$31.51 M
|
-$25.25 M
|
| EBITDA Ratio |
-0.01 |
0.01 |
0.1 |
0.02 |
-0.08 |
-0.01 |
-0.09 |
0.38 |
-4.64 |
0 |
| Operating Income Ratio
|
-0.04
|
-0.04
|
0.03
|
-0.04
|
-0.14
|
-0.08
|
-0.17
|
-0.93
|
-0.44
|
0
|
| Total Other
Income/Expenses Net |
-$131.19 M
|
-$65.72 M
|
$12.61 M
|
-$67.69 M
|
-$18.23 M
|
-$6.67 M
|
-$3.56 M
|
-$114,000.00
|
$386.26 M
|
-$25.25 M
|
| Income Before Tax |
-$202.41 M |
-$62.08 M |
-$29.80 M |
-$337.80 M |
-$327.12 M |
-$54.15 M |
-$76.40 M |
-$237.53 M |
$343.29 M |
-$25.25 M |
| Income Before Tax Ratio
|
-0.1
|
-0.05
|
-0.03
|
-0.33
|
-0.39
|
-0.09
|
-0.18
|
-0.93
|
3.54
|
0
|
| Income Tax Expense |
-$89.37 M |
-$43.38 M |
$483,000.00 |
-$3.55 M |
-$21.54 M |
$40,000.00 |
-$6.64 M |
-$10.76 M |
$23.48 M |
$0.00 |
| Net Income |
-$113.04 M |
-$18.70 M |
-$30.28 M |
-$334.25 M |
-$305.58 M |
-$52.66 M |
-$60.67 M |
-$159.74 M |
$332.49 M |
-$25.25 M |
| Net Income Ratio |
-0.06 |
-0.01 |
-0.03 |
-0.33 |
-0.36 |
-0.08 |
-0.14 |
-0.63 |
3.43 |
0 |
| EPS |
-1.28 |
-0.2 |
-0.35 |
-3.94 |
-3.71 |
-0.68 |
-0.94 |
-3.55 |
13.14 |
-0.66 |
| EPS Diluted |
-1.28 |
-0.2 |
-0.35 |
-3.94 |
-3.71 |
-0.68 |
-0.94 |
-3.55 |
6.93 |
-0.66 |
| Weighted Average Shares
Out |
$111.25 M
|
$93.70 M
|
$86.07 M
|
$84.93 M
|
$82.36 M
|
$77.34 M
|
$64.35 M
|
$45.00 M
|
$25.13 M
|
$38.23 M
|
| Weighted Average Shares
Out Diluted |
$111.25 M
|
$93.70 M
|
$86.07 M
|
$84.93 M
|
$82.36 M
|
$77.34 M
|
$64.35 M
|
$45.03 M
|
$46.14 M
|
$38.23 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
